Valuation: Scinai Immunotherapeutics Ltd.

Market Cap 954K 837K 775K 713K 1.35M 91.34M 1.38M 9.24M 3.62M 44.85M 3.58M 3.51M 155M P/E 2024 *
-
P/E 2025 -0.2x
Enterprise Value 1.56M 1.37M 1.27M 1.17M 2.21M 149M 2.25M 15.11M 5.93M 73.34M 5.86M 5.73M 253M EV / Sales 2024
4,521,684x
EV / Sales 2025 2,346,088x
Free-Float
0.36%
Yield 2024 *
-
Yield 2025 -
1 day-3.87%
1 week-10.34%
Current month-4.59%
1 month-27.19%
3 months-59.29%
6 months-70.96%
Current year-66.16%
1 week 0.24
Extreme 0.2409
0.27
1 month 0.24
Extreme 0.2408
0.39
Current year 0.24
Extreme 0.2408
1.12
1 year 0.24
Extreme 0.2408
3.48
3 years 0.24
Extreme 0.2408
15.5
5 years 0.24
Extreme 0.2408
419
10 years 0.24
Extreme 0.2408
6,199.99
Manager TitleAgeSince
Chief Executive Officer 51 02/03/2021
Director of Finance/CFO 54 01/01/2007
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 77 30/09/2019
Director/Board Member 64 24/03/2020
Director/Board Member 71 24/03/2020
Date Insider Type Main position Quantity % Market Cap.
16/06Free

Chairman

120,000,000 0.5984%
16/06Free

Chief Executive Officer

400,000,000 1.9946%
18/03Other

Director

57,400,000 1.6823%
Change 5-day change 1-year change 3-year change Capi.($)
-3.87%-10.34%-89.59%-98.38% 954K
-1.02%+1.50%+3.26%+7.09% 50.61B
-1.57%-3.18%+383.82%+593.37% 39.11B
-0.14%+0.77%+27.49%-5.50% 34.64B
+1.76%-1.78%+21.44%+53.38% 33.79B
-0.06%-0.45%+2.94%+28.70% 26.89B
-1.93%-1.01% - - 16.47B
-1.49%-6.18%+63.89%+120.53% 15.14B
-1.12%-0.32%+14.20%+16.44% 13.85B
-0.97%-2.83%+10.35%-33.29% 12.72B
Average -0.98%-2.37%+48.64%+75.81% 24.32B
Weighted average by Cap. -0.50%-1.08%+80.38%+121.62%

Financials

2024 2025
Net sales 0.66 0.58 0.53 0.49 0.93 62.98 0.95 6.37 2.5 30.93 2.47 2.42 106.81 1.31 1.15 1.07 0.98 1.85 125.48 1.89 12.69 4.98 61.62 4.92 4.82 212.8
Net income 4.8M 4.21M 3.9M 3.58M 6.78M 459M 6.91M 46.44M 18.21M 225M 18.01M 17.62M 778M -8.31M -7.29M -6.75M -6.21M -11.74M -795M -11.97M -80.43M -31.55M -390M -31.19M -30.51M -1.35B
Net Debt 122K 107K 99.11K 91.19K 172K 11.68M 176K 1.18M 463K 5.73M 458K 448K 19.8M 606K 532K 492K 453K 857K 58M 873K 5.87M 2.3M 28.48M 2.28M 2.23M 98.37M
Logo Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Employees
45
Date Price Change Volume
13/07/26 USD 0.2410 -3.87% 87,799
10/07/26 USD 0.2507 -2.83% 38,930
09/07/26 USD 0.2580 -4.44% 91,826
08/07/26 USD 0.2700 +4.69% 103,632
07/07/26 USD 0.2579 -4.06% 97,497

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCNI Stock